Cargando…
Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
The gut microbiota is altered in liver diseases, and several probiotics have been shown to reduce the degree of liver damage. We hypothesized that oral administration of specific Bifidobacterium strains isolated from healthy guts could attenuate liver injury. Five strains were tested in this study....
Autores principales: | Fang, Daiqiong, Shi, Ding, Lv, Longxian, Gu, Silan, Wu, Wenrui, Chen, Yanfei, Guo, Jing, Li, Ang, Hu, Xinjun, Guo, Feifei, Ye, Jianzhong, Li, Yating, Li, Lanjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562910/ https://www.ncbi.nlm.nih.gov/pubmed/28821814 http://dx.doi.org/10.1038/s41598-017-09395-8 |
Ejemplares similares
-
Multiple Intestinal Bacteria Associated with the Better Protective Effect of Bifidobacterium pseudocatenulatum LI09 against Rat Liver Injury
por: Zha, Hua, et al.
Publicado: (2022) -
Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl(4)-induced liver cirrhosis by protecting the intestinal barrier in rats
por: Shi, Ding, et al.
Publicado: (2017) -
Cloning, Expression, Purification, and Characterization of β-Galactosidase from Bifidobacterium longum and Bifidobacterium pseudocatenulatum
por: Du, Mingzhu, et al.
Publicado: (2022) -
Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure
por: Wang, Kaicen, et al.
Publicado: (2020) -
Xylan utilisation promotes adaptation of Bifidobacterium pseudocatenulatum to the human gastrointestinal tract
por: Watanabe, Yohei, et al.
Publicado: (2021)